653 related articles for article (PubMed ID: 20413653)
1. Molecular mechanisms of neurodegeneration in Alzheimer's disease.
Crews L; Masliah E
Hum Mol Genet; 2010 Apr; 19(R1):R12-20. PubMed ID: 20413653
[TBL] [Abstract][Full Text] [Related]
2. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
4. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
5. Aβ toxicity in Alzheimer's disease.
Cavallucci V; D'Amelio M; Cecconi F
Mol Neurobiol; 2012 Apr; 45(2):366-78. PubMed ID: 22415442
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
7. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
[TBL] [Abstract][Full Text] [Related]
8. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology.
Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM
Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782
[TBL] [Abstract][Full Text] [Related]
9. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
10. Synaptic changes in Alzheimer's disease and its models.
Pozueta J; Lefort R; Shelanski ML
Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
[TBL] [Abstract][Full Text] [Related]
11. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
12. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease.
Jeong S
Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
[TBL] [Abstract][Full Text] [Related]
15. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
16. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
17. Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisal.
Kuruva CS; Reddy PH
Drug Discov Today; 2017 Feb; 22(2):223-233. PubMed ID: 27794478
[TBL] [Abstract][Full Text] [Related]
18. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
Hashimoto M; Rockenstein E; Crews L; Masliah E
Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
20. Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice.
Shin SJ; Jeong YO; Jeon SG; Kim S; Lee SK; Nam Y; Park YH; Kim D; Lee YS; Choi HS; Kim JI; Kim JJ; Moon M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30551564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]